Skip to main content

(Approval lapsed) FRESENIUS PROPOVEN 1% propofol 1g/100mL emulsion for injection or infusion

Section 19A approved medicine
(Approval lapsed) FRESENIUS PROPOVEN 1% propofol 1g/100mL emulsion for injection or infusion
Section 19A approval holder
Fresenius Kabi Australia Pty Limited ABN 39 109 383 593
Phone
1300 732 001
Approved until
Status
Expired
Medicines in short supply/unavailable
FRESOFOL 1% MCT/LCT propofol 500mg/50mL emulsion for intravenous injection/infusion vial - ARTG 193609
Indication(s)

FRESENIUS PROPOVEN 1% propofol 1g/100mL emulsion for injection or infusion is a short-acting intravenous general anaesthetic for:

  • induction of general anaesthesia in adults and children aged one month and older.
  • maintenance of general anaesthesia in adults and children aged 3 years and older.
  • maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided.
  • sedation of ventilated adults receiving intensive care.
  • Monitored conscious sedation in adults for surgical and diagnostic procedures.

Help us improve the Therapeutic Goods Administration site